Viewing nowOlgotan Tablet 20mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

MFDS item code 201101021 · Approved 2011.02.28 · Insurance code 641704130
Treatment of essential hypertension
This medication is used for the treatment of essential hypertension. It helps to control blood pressure within the normal range, reducing the risk of cardiovascular complications. Regular use along with lifestyle modifications can effectively manage blood pressure.
<Adults> The recommended initial dose is 10 mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase to 20 mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40 mg once daily. The blood pressure-lowering effect is evident within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day, if possible (e.g., in the morning). In patients who may have reduced effective intravascular volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended that treatment be started at a low dose with careful monitoring of their condition. <Elderly patients> No dosage adjustment is necessary when administering this drug to patients aged 65 years or older. Although no overall differences in efficacy or safety were observed between elderly and younger patients, it cannot be ruled out that some elderly patients may have a more sensitive response. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20 mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10 mg once daily, which may be increased to a maximum of 20 mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.
<Pediatric patients> Safety and efficacy in pediatric patients have not been established.
This medication can cause severe harm or death to a fetus or newborn if taken during the second and third trimesters of pregnancy, therefore it should be stopped immediately upon confirmation of pregnancy. Individuals with allergies to this medication or its components, those who are pregnant or breastfeeding, patients undergoing kidney dialysis, those with severe liver dysfunction, patients with bile duct obstruction, and individuals with lactose intolerance should not take this medication. Patients with reduced blood volume or sodium levels, those with impaired kidney function, patients with renal artery hypertension, those at risk of hyperkalemia, patients with aortic or mitral stenosis, and patients with primary aldosteronism should use this medication with caution and be closely monitored at the onset of treatment. Side effects may include dizziness, headache, abdominal pain, nausea, chest pain, and peripheral edema; there may be rare cases of angioedema or liver function abnormalities. Chronic diarrhea and weight loss similar to chronic malabsorption syndrome have been reported; if such symptoms occur, discontinue the medication immediately and consult a doctor. This medication may cause the blood potassium levels to rise dangerously when taken with potassium-sparing diuretics or potassium supplements, so caution is necessary, and it may increase the blood pressure-lowering effect when used with other antihypertensives. If taken with lithium preparations, the serum lithium levels may increase, leading to toxicity, thus concomitant use is not recommended. Taking this medication with non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of kidney function deterioration; kidney function should be regularly monitored during treatment. This medication should not be taken during pregnancy, especially in the second and third trimesters, and breastfeeding should be discontinued or the medication should be stopped, as adverse reactions may occur in infants. Safety and efficacy in pediatric patients have not been established, so it is not recommended for use in children. In elderly patients, due to the possibility of elevated serum drug concentrations, dose adjustment and careful monitoring are required. In cases of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, and immediate medical attention is necessary.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and humidity, so it should be stored in a tightly sealed container. Additionally, it should be kept at room temperature between 1 to 25 degrees Celsius, away from extremes of heat or cold, to maintain its effectiveness for a longer period.
White round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 20mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.